Literature DB >> 18801648

Interregional cerebral metabolic associativity during a continuous performance task (Part II) : differential alterations in bipolar and unipolar disorders.

Brenda E Benson1, Mark W Willis, Terence A Ketter, Andrew Speer, Tim A Kimbrell, Mark S George, Peter Herscovitch, Robert M Post.   

Abstract

Unipolar and bipolar disorders have often been reported to exhibit abnormal regional brain activity in prefrontal cortex and paralimbic structures compared with healthy controls. We sought to ascertain how regions postulated to be abnormal in bipolar and unipolar disorders were functionally connected to the rest of the brain, and how this associativity differed from healthy controls. Thirty patients with bipolar disorder (BPs), 34 patients with unipolar disorder (UPs), and 66 healthy volunteers (Willis, M.W., Benson, B.E., Ketter, T.A., Kimbrell, T.A., George, M.S., Speer, A.M., Herscovitch, P., Post, R.M., 2008. Interregional cerebral metabolic associativity during a continuous performance task in healthy adults. Psychiatry Research: Neuroimaging 164 (1)) were imaged using F-18-fluorodeoxyglucose and positron emission tomography (FDG-PET) while performing an auditory continuous performance task (CPT). Five bilateral regions of interest (ROIs), namely dorsolateral prefrontal cortex (DLPFC), insula, inferior parietal cortex (INFP), thalamus and cerebellum, were correlated with normalized cerebral metabolism in the rest of the brain while covarying out Hamilton Depression Rating Scale Scores. In bipolar patients compared with controls, metabolism in the left DLPFC and INFP, and bilateral thalamus and insula had more positive and fewer negative metabolic correlations with other brain regions. In contrast, compared with controls, unipolar patients had fewer significant correlative relationships, either positive or negative. In common, bipolar and unipolar patients lacked the normal inverse relationships between the DLPFC and cerebellum, as well as relationships between the primary ROIs and other limbic regions (medial prefrontal cortex, anterior cingulate, and temporal lobes) compared with controls. Associations of DLPFC and INFP with other brain areas were different in each hemisphere in patients and controls. Bipolar patients exhibited exaggerated positive coherence of activity throughout the brain, while unipolar patients showed a paucity of normal interrelationships compared with controls. These abnormal patterns of metabolic associativity suggest marked interregional neuronal dysregulation in bipolar and unipolar illness exists beyond that of mere absolute regional differences from control levels, and provides rationale for using acute and long-term therapies that may re-establish and maintain normal associativity in these devastating illnesses.

Entities:  

Mesh:

Year:  2008        PMID: 18801648     DOI: 10.1016/j.pscychresns.2007.12.016

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  Alterations of the cerebellum and basal ganglia in bipolar disorder mood states detected by quantitative T1ρ mapping.

Authors:  Casey P Johnson; Gary E Christensen; Jess G Fiedorowicz; Merry Mani; Joseph J Shaffer; Vincent A Magnotta; John A Wemmie
Journal:  Bipolar Disord       Date:  2018-01-07       Impact factor: 6.744

2.  Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders.

Authors:  Brenda E Benson; Mark W Willis; Terence A Ketter; Andrew Speer; Tim A Kimbrell; Peter Herscovitch; Mark S George; Robert M Post
Journal:  J Affect Disord       Date:  2014-06-02       Impact factor: 4.839

3.  Aberrant cerebellar connectivity in bipolar disorder with psychosis.

Authors:  Ann K Shinn; Youkyung S Roh; Caitlin T Ravichandran; Justin T Baker; Dost Öngür; Bruce M Cohen
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-07

4.  Neuroticism and extraversion mediate the association between loneliness and the dorsolateral prefrontal cortex.

Authors:  Xia Kong; Dongtao Wei; Wenfu Li; Lingli Cun; Song Xue; Qinglin Zhang; Jiang Qiu
Journal:  Exp Brain Res       Date:  2014-09-19       Impact factor: 1.972

Review 5.  Mechanisms of illness progression in the recurrent affective disorders.

Authors:  Robert M Post
Journal:  Neurotox Res       Date:  2010-11       Impact factor: 3.911

6.  The Impact of Transcranial Direct Current Stimulation (tDCS) on Bipolar Depression, Mania, and Euthymia: a Systematic Review of Preliminary Data.

Authors:  Clément Dondé; Nicholas H Neufeld; Pierre A Geoffroy
Journal:  Psychiatr Q       Date:  2018-12

7.  Prefronto-cerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder.

Authors:  Amedeo Minichino; Francesco Saverio Bersani; Laura Bernabei; Francesco Spagnoli; Lucilla Vergnani; Alessandra Corrado; Ines Taddei; Massimo Biondi; Roberto Delle Chiaie
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-28       Impact factor: 2.570

8.  Pilot Study: The Role of the Hemispheric Lateralization in Mental Disorders by Use of the Limb (Eye, Hand, Foot) Dominance.

Authors:  Naser Goodarzi; Parviz Dabbaghi; Habib Valipour; Behnam Vafadari
Journal:  Basic Clin Neurosci       Date:  2015-04

9.  Prefrontocerebellar transcranial direct current stimulation increases amplitude and decreases latency of P3b component in patients with euthymic bipolar disorder.

Authors:  Francesco Saverio Bersani; Amedeo Minichino; Francesco Fattapposta; Laura Bernabei; Francesco Spagnoli; Daniela Mannarelli; Marta Francesconi; Caterina Pauletti; Alessandra Corrado; Lucilla Vergnani; Ines Taddei; Massimo Biondi; Roberto Delle Chiaie
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-19       Impact factor: 2.570

10.  Dissociable self effects for emotion regulation: a study of Chinese major depressive outpatients.

Authors:  Xiaoxia Wang; Zhengzhi Feng; Daiquan Zhou; Xu Lei; Tongquan Liao; Li Zhang; Bing Ji; Jing Li
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.